Tirzepatide decreased numerous measures of appetite or the drive to eat ... two important hormone pathways that help control hunger. As of today, there are no medications on the market that purely ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Roughly one in three preteens and teens ages 12 to 17 in the United States had prediabetes in 2023, according to new data ...

Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...

(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...

Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side ...

“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...

Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

Researchers observe reduced activity in parts of the brain that control hunger in patients taking tirzepatide. News . Published: July 10, 2025 . Original story from Pennington Biomedical Research ...